All Journals > The Journal of Infectious Diseases > 15 August 2007 > HCV Quasispecies after Liver Transplant

Article Tools

Search for Related Articles

  • By Author
  • Search In

Announcements

Science Watch logo

JID Article Named "New Hot Paper" by ScienceWatch.com

Dr. Lauri Hicks' 2007 article on pneumococcal disease has been named a "hot new paper" by Thompson Reuters' ScienceWatch.com. Read a Q&A about the article with Dr. Hicks here

Press Release

Unique Collaboration Charts the Migrations of a Parasite that Affected History
Researchers Sequence Louse DNA from Mummies and Propose New Model for its Development


In the News

Featured in Grist
"Another symptom of swine flu: instant amnesia" May 11, 2009
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas
Eileen Thacker and Bruce Janke
Read the veterinary literature on swine flu and you get a strong sense of what might be called vaccination treadmill: the hog industry is literally scrambling to generate new vaccines for the rapidly evolving flu strains that sweep through CAFOs. Writing in the Journal of Infectious Diseases [PDF] in 2008, Eileen Thacker and Bruce Janke of Iowa State University paint a stark picture: “A number of genetically diverse viruses are circulating in swine herds throughout the world and are a major cause of concern to the swine industry,” they write. “Influenza virus infections in swine and poultry are potential sources of viruses for the next pandemic among humans.”

Featured in New York Times
"Fear of a Swine Flu Epidemic in 1976 Offers Some Lessons, and Concerns, Today" May 8, 2009
Anti‐Ganglioside Antibody Induction by Swine (A/NJ/1976/H1N1) and Other Influenza Vaccines: Insights into Vaccine‐Associated Guillain‐Barré Syndrome
Irving Nachamkin, Sean V. Shadomy, Anthony P. Moran, Nancy Cox, Collette Fitzgerald, Huong Ung, Adrian T. Corcoran, John K. Iskander, Lawrence B. Schonberger, and Robert T. Chen
Irving Nachamkin, a professor of pathology and laboratory medicine at the University of Pennsylvania, examined some 1976 vaccine that had been saved by a scientist in Texas. In a paper published last year in The Journal of Infectious Diseases, he and colleagues reported that mice given the vaccine made antibodies that reacted with gangliosides, which are components of nerve cells. An antibody attack on gangliosides is part of the disease mechanism of Guillain-Barré.

Featured in AFP
"Swine flu vaccine 'could be ready soon'" May 7, 2009
A Broadly Protective Vaccine against Globally Dispersed Clade 1 and Clade 2 H5N1 Influenza Viruses
Mary A. Hoelscher, Neetu Singh, Sanjay Garg, Lakshmi Jayashankar, Vic Veguilla, Aseem Pandey, Yumi Matsuoka, Jacqueline M. Katz, Ruben Donis, Suresh K. Mittal, and Suryaprakash Sambhara
The vaccine Mittal created for the bird flu worked on three different strains isolated over a seven-year period and was described in papers for the Journal of Infectious Diseases and the journal Clinical Pharmacology and Therapeutics.

Featured in Newsweek
"The Path of a Pandemic" http://www.newsweek.com/id/195692
Swine Influenza Virus: Zoonotic Potential and Vaccination Strategies for the Control of Avian and Swine Influenzas
Eileen Thacker and Bruce Janke
Last year researchers from Iowa State University in Ames warned that pigs located in industrial-scale farms were being subjected to influenza infections from farm poultry, wild birds and their human handlers. Writing in The Journal of Infectious Diseases, Eileen Thacker and Bruce Janke said, "As a result of the constantly changing genetic makeup of individual influenza viruses in pigs, the U.S. swine industry is continually scrambling to respond to the influenza viruses circulating within individual production systems."

15 August 2007

Volume 196, Number 4
The Journal of Infectious Diseases 2007;196:528–536
0022-1899/2007/19604-0007$15.00
DOI: 10.1086/519691
MAJOR ARTICLE

Early Evolution of Hepatitis C Virus (HCV) Quasispecies after Liver Transplant for HCV‐Related Disease

Evelyne Schvoerer,1,4,5

Eric Soulier,4

Cathy Royer,4

Anne‐Catherine Renaudin,1

Christine Thumann,4

Samira Fafi‐Kremer,1,4,5

Nicolas Brignon,4

Stéphane Doridot,4

Nicolas Meyer,2

Patricia Pinson,6

Bernard Ellero,3

Marie‐Lorraine Woehl‐Jaegle,3

Carole Meyer,3

Philippe Wolf,3

Pierre Zachary,1

Thomas Baumert,4,5 and

Françoise Stoll‐Keller1,4,5

1Laboratoire de Virologie and 2Département d’Information Médicale, Hôpital Civil, and 3Centre de Chirurgie Viscérale et de Transplantation, Hôpital de Hautepierre, Centre Hospitalier Régional Universitaire de Strasbourg, 4Unité INSERM 748, and 5Université Louis Pasteur, Faculté de Médecine, Strasbourg, and 6Centre Hospitalier Universitaire de Bordeaux, Laboratoire de Virologie Hôpital Pellegrin, Bordeaux, France

Background.End‐stage liver disease as a result of chronic hepatitis C virus (HCV) infection is the main indication for liver transplant (LT), but allografts are systematically infected with HCV soon after transplant. Viral quasispecies are poorly described during the early posttransplant period.

Methods.For 17 patients who received an LT for HCV disease, plasma viral quasispecies evolution was determined by sequence analysis of hypervariable region 1 of the E2 envelope gene before transplant (BT), after 7 days (D7), and after 1 month (M1). T helper (Th)1/Th2 cytokine levels were determined concomitantly.

Results.HCV quasispecies showed a significant decrease in amino acid diversity at D7 and M1, compared with BT ( ). A correlation was observed between low plasma tumor necrosis factor–α levels at D7 and decreased quasispecies amino acid complexity at the same date. Nucleic acid diversity was lower for genotype 1 than for genotype 3 infection ( ). The complexity and diversity of amino acids were lower in patients with hepatocellular carcinoma (HCC) BT than in those without HCC ( ). Conserved amino acid residues within quasispecies were shared by the whole cohort before and after LT.

Conclusion.Viral structural and/or host immunological features could favor the emergence of fitter HCV strains after LT.

Received 27 November 2006; accepted 21 February 2007; electronically published 29 June 2007.

Reprints or correspondence: Dr. Evelyne Schvoerer, Institut de Virologie, 3 Rue Koeberlé, 67000 Strasbourg, France ().

Cited by

I. M. V. G. C. Mello, C. Thumann, E. Schvoerer, E. Soulier, J. R. R. Pinho, D. A. M. M. Silvestre, A. T. L. Queiroz, P. Wolf, T. F. Baumert, F. S. Keller, C. A. Pereira. (2009) Conservation of hepatitis C virus nonstructural protein 3 amino acid sequence in viral isolates during liver transplantation. Journal of Viral Hepatitis
Online publication date: 1-Apr-2009.
CrossRef
Frédéric Schramm, Eric Soulier, Cathy Royer, Thierry Weitten, Samira Fafi‐Kremer, Nicolas Brignon, Nicolas Meyer, Bernard Ellero, Marie‐Lorraine Woehl‐Jaegle, Carole Meyer, Philippe Wolf, Michel Doffoël, Thomas F. Baumert, Françoise Stoll‐Keller, and Evelyne Schvoerer. (2008) Frequent Compartmentalization of Hepatitis C Virus with Leukocyte‐Related Amino Acids in the Setting of Liver Transplantation. The Journal of Infectious Diseases 198:11, 1656-1666
Online publication date: 1-Dec-2008.
Arthur Y Kim, Joerg Timm. (2008) Resistance mechanisms in HCV: from evolution to intervention. Expert Review of Anti-infective Therapy 6:4, 463-478
Online publication date: 1-Sep-2008.
CrossRef
Daisuke Sasaki, Kazuyuki Sugahara, Naoko Inokuchi, Katunori Yanagihara, Hiroo Hasegawa, Sayaka Mori, Yasuaki Yamada, Shimeru Kamihira. (2008) Screening for genetic heterogeneity in the interferon sensitivity determining region of the hepatitis C virus genome by polymerase chain reaction with melting curve analysis. Clinical Chemistry and Laboratory Medicine 46:7, 966-973
Online publication date: 1-Aug-2008.
CrossRef
  • Potential conflicts of interest: none reported.

    Financial support: Cellule d’Essais Cliniques des Hôpitaux Universitaires de Strasbourg; CHRU Strasbourg (Projet Hospitalier de Recherche Clinique 2864 et Appel à Projets Internes).

Close Popup